期刊文献+

PCI围术期患者发生出血危险因素分析 被引量:1

The risk factors of perioperative hemorrhage occurred in patients undergoing PCI
下载PDF
导出
摘要 目的:分析接受经皮冠状动脉介入治疗(PCI)围术期患者发生出血的危险因素。方法:回顾性分析572例接受PCI手术的患者,回归分析发生出血可能的危险因素,数据分析应用SPSS12.0完成。结果:女性、年龄、肾小球滤过率、心源性休克、急诊PCI、慢性阻塞性肺疾病、体重、手术操作时间、糖尿病及联合使用抗凝剂过量与出血相关。结论:出血的最主要危险因素为女性、体重轻、血小板Ⅱb/Ⅲa受体拮抗剂用量、急诊及心源性休克。 Objective: To analyze the acceptance of PCI perioperative bleeding in patients with risk factors. Methods: The data of 572 patients with PCI surgery were retrospectively analyzed, included regression analysis of the risk factors, the data analysis were applied SPSS 12.0. Results: Female, age, glomerular filtration rate, cardiogenic shock, emergency PCI, chronic obstructive pulmonary disease, body weight, surgery time, diabetes and joint use of anticoagulants and excessive bleeding. Conclusion: The main risk factors for bleeding women, weight, platelet Ⅱb/Ⅲa receptor antagonist use, emergency and cardiogenic shock.
出处 《中国医药导报》 CAS 2010年第25期28-29,共2页 China Medical Herald
关键词 PCI 围术期出血 危险因素 PCI Perioperative bleeding Risk factors
  • 相关文献

参考文献6

  • 1Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary. Events (GRACE) [J]. Eur Heart J,2003,24(20):1815-1823. 被引量:1
  • 2Fuchs S, Kornowski R, Teplitsky I, et al. Major bleeding complicating contemporary primary percutaneous coronary, interventions-incidence, predictors, and prognostic implications [J]. Cardiovase Revasc Med,2009, 10(1):88-93. 被引量:1
  • 3Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions [J]. Am J Cardiot,2003.92(8):930- 935. 被引量:1
  • 4Fuchs S, Kornowski R. Major bleeding complicating contemporary primary percutaneous coronary intervcntions-incidenee, predictors and prognostic implications [J]. Cardiovasc Revasc Med,2009,10(2):88-93. 被引量:1
  • 5Blankenship JC, Hellkamp AS, Aguirre FV, et al. Nascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of lsehemie Complications (EPIC) trial [J]. Am J Cardiol,1998,81(1):36-40. 被引量:1
  • 6Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung and Blood Institute Dynamic Registry [J] Catheter Cardiovasc lnterv,2007,169(7):961- 966. 被引量:1

同被引文献3

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部